Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ASBP

Aspire Biopharma Holdings Inc

Mar 21 • 04:00PM ET

0.6304

Dollar change -0.0578
Percentage change -8.40	%

Healthcare • Biotechnology • USA • NASD

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.43	Insider Own	26.06%	Shs Outstand	46.01M	Perf Week	1.68%
Market Cap	29.00M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	34.02M	Perf Month	-89.77%
Income	-3.76M	PEG	-	EPS next Q	-	Inst Own	1.01%	Short Float	0.14%	Perf Quarter	-94.62%
Sales	0.00M	P/S	-	EPS this Y	-	Inst Trans	1.88%	Short Ratio	0.08	Perf Half Y	-94.35%
Book/sh	0.01	P/B	54.20	EPS next Y	-	ROA	-28.30%	Short Interest	0.05M	Perf Year	-93.93%
Cash/sh	0.00	P/C	-	EPS next 5Y	-	ROE	-38.21%	52W Range	0.52 - 15.80	Perf YTD	-94.52%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-4161.59%	52W High	-96.01%	Beta	0.75
Dividend TTM	-	Quick Ratio	0.01	Sales past 5Y	0.00%	Gross Margin	-	52W Low	21.23%	ATR (14)	0.63
Dividend Ex-Date	Jul 14, 2005	Current Ratio	0.01	EPS Y/Y TTM	-325.44%	Oper. Margin	-	RSI (14)	23.37	Volatility	14.98% 27.09%
Employees	2	Debt/Eq	59.33	Sales Y/Y TTM	-	Profit Margin	-	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	0.00	EPS Q/Q	-798.70%	Payout	0.00%	Rel Volume	0.72	Prev Close	0.69
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	-	Avg Volume	598.17K	Price	0.63
SMA20	-36.01%	SMA50	-91.08%	SMA200	-93.82%	Trades		Volume	430,300	Change	-8.40%

Mar-20-25 08:30AM	Aspire Biopharma Holdings, Inc., Contract Manufacturer, Glatt Air Techniques, Inc., has Completed Its First Good Manufacturing Practice ('GMP') Clinical Batch of Pharmaceutical Grade Oral Mucosal Fast Acting Formulation of Aspirin (ACCESSWIRE)
Mar-13-25 08:30AM	Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform (ACCESSWIRE) -21.62%
Mar-11-25 08:00AM	An Interview with the CEO: How Aspire Biopharma is Disrupting a $100 Billion Market with Sublingual Innovation (Newsfile)
Mar-03-25 07:30AM	Aspire Biopharma Holdings, Inc., to Launch the Next Generation of Pre-Workout Performance Supplement (ACCESSWIRE) -32.67%
Feb-25-25 07:30AM	Aspire Biopharma Holdings, Inc., Provides an Update on Lead Product Candidate: High-Dose, Sublingual Aspirin (ACCESS Newswire) -21.43%
06:15PM	Loading…
Feb-20-25 06:15PM	Aspire Biopharma Holdings, Inc. Announces the Execution of Securities Purchase Agreement (ACCESSWIRE) -33.33% -58.44%
07:30AM	Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq (ACCESSWIRE)
Feb-19-25 01:10PM	Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq (ACCESSWIRE)
Sep-03-24 08:01AM	Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements (GlobeNewswire)
Jul-31-24 08:01AM	Aspire Biopharma, Inc. Signs Letter of Intent to Create a Publicly Listed, Drug Delivery Company Through a Business Combination with PowerUp Acquisition Corp. (GlobeNewswire)
Jun-05-24 04:05PM	PowerUp Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q (GlobeNewswire)
May-20-24 05:11PM	PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders (GlobeNewswire)
May-16-24 04:05PM	PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders (GlobeNewswire) +7.62%
Jan-29-24 08:01AM	PowerUp Acquisition Corp. and Visiox Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form S-4 to the SEC in Connection with the Previously Announced Proposed Business Combination (GlobeNewswire)
Dec-27-23 08:01AM	Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp. (GlobeNewswire)

Aspire Biopharma Holdings, Inc. operates as a biopharmaceutical company that engaged in developing and marketing a disruptive technology for drugs, nutraceuticals & supplements. The company was founded on February 2, 2025 and is headquartered in Humacao, Puerto Rico.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ASBP

Aspire Biopharma Holdings Inc

Upgrade your FINVIZ experience